Wordt geladen...
Agonist actions of dihydroergotamine at 5-HT(2B) and 5-HT(2C) receptors and their possible relevance to antimigraine efficacy
1. The pharmaceutical compound, dihydroergotamine (DHE) is dispensed to prevent and reduce the occurrence of migraine attacks. Although still controversial, the prophylactic effect of this drug is believed to be caused through blockade and/or activation of numerous receptors including serotonin (5-H...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2003
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1574033/ https://ncbi.nlm.nih.gov/pubmed/12970106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705437 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|